[Clinical significance of serum soluble interleukin-2 receptor (sIL-2R) determination in patients with rheumatoid arthritis]. 1996

M Takemura, and M Seishima, and A Noma, and C Kasai, and M Satoh, and T Morita, and S Takeuchi
Central Clinical Laboratory, Gifu University Hospital.

It has been recently shown that soluble interleukin-2 receptor (sIL-2R) is related to the pathogenesis of autoimmune diseases. We determined serum levels of sIL-2R in patients with rheumatoid arthritis (RA). Fifty-three patients (3 males and 50 females from 35 to 70 years old) and sex- and age-matched 50 healthy subjects were included in this study. The sIL-2R concentrations positively correlated with Lansbury index of RA (r = 0.602, p < 0.01). There was a significant correlation between sIL-2R levels and the prevalence of CD3+.HLA-DR+ lymphocytes (r = 0.420, p < 0.01).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

M Takemura, and M Seishima, and A Noma, and C Kasai, and M Satoh, and T Morita, and S Takeuchi
January 2001, Folia histochemica et cytobiologica,
M Takemura, and M Seishima, and A Noma, and C Kasai, and M Satoh, and T Morita, and S Takeuchi
January 1993, Zhonghua zhong liu za zhi [Chinese journal of oncology],
M Takemura, and M Seishima, and A Noma, and C Kasai, and M Satoh, and T Morita, and S Takeuchi
December 1994, Journal of endocrinological investigation,
M Takemura, and M Seishima, and A Noma, and C Kasai, and M Satoh, and T Morita, and S Takeuchi
January 1990, Zeitschrift fur Rheumatologie,
M Takemura, and M Seishima, and A Noma, and C Kasai, and M Satoh, and T Morita, and S Takeuchi
January 2004, Annals of clinical and laboratory science,
M Takemura, and M Seishima, and A Noma, and C Kasai, and M Satoh, and T Morita, and S Takeuchi
April 1997, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
M Takemura, and M Seishima, and A Noma, and C Kasai, and M Satoh, and T Morita, and S Takeuchi
April 1992, Bollettino della Societa italiana di biologia sperimentale,
M Takemura, and M Seishima, and A Noma, and C Kasai, and M Satoh, and T Morita, and S Takeuchi
January 2004, Clinical transplantation,
M Takemura, and M Seishima, and A Noma, and C Kasai, and M Satoh, and T Morita, and S Takeuchi
January 2004, Roczniki Akademii Medycznej w Bialymstoku (1995),
M Takemura, and M Seishima, and A Noma, and C Kasai, and M Satoh, and T Morita, and S Takeuchi
January 1993, Anticancer research,
Copied contents to your clipboard!